Alan Gross, PharmD, BCPS-AQID, Clinical Assistant Professor, Pharmacy Practice, University of Illinois at Chicago, College of Pharmacy, discusses testing options for multidrug-resistant pneumonia.
“There are a couple of PCR based tests [for multidrug-resistant pneumonia]. We’ve had respiratory viral panels for pneumonia to help look at multiple respiratory viruses in addition to atypical bacteria, so that’s actually already in place in the United States, and we’ve been using that with pretty good effect.
But there [is] some additional testing coming from multiple different platforms, that [are] really identifying bacterial pathogens in addition to atypicals—so, your Streptococcus pneumoniae from [bronchoalveolar lavage] BAL, Haemophilus influenzae, things like that.
And so, if we get that data in a patient, and we get it quick, that can really help target our antibiotics and decrease unnecessary broad-spectrum agent use.”
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
We break down our top HIV news stories of 2017. Did you read them all?
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512